A study of ADXS-NEO for the treatment of cancer

Trial Profile

A study of ADXS-NEO for the treatment of cancer

Planning
Phase of Trial: Phase I

Latest Information Update: 13 Jun 2017

At a glance

  • Drugs ADXS NEO (Primary)
  • Indications Cancer; Solid tumours
  • Focus Adverse reactions; First in man
  • Most Recent Events

    • 13 Jun 2017 According to an Advaxis media release, the FDA has accepted the ADXS-NEO IND in March 2017.
    • 12 Aug 2016 New trial record
    • 02 Aug 2016 According to an Advaxis media release, clinical trials are expected to begin in the year 2017.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top